Certified Advisory Corp
- SEC CIK
- 0001731732
- Latest filing
- Jul 16, 2026
The latest 13F from Certified Advisory Corp covers Q2 2026 (filed Jul 16, 2026): 327 long positions worth $1.24B. The top 10 holdings make up 24.7% of the portfolio, and the largest is Vanguard Morningstar Growth ETF at 4.0%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 22
- Est. +$7.62M
- Added
- 148
- Est. +$82.0M
- Reduced
- 133
- Est. −$63.6M
- Sold out
- 13
- Est. −$14.2M
Top 5 holdings
Share of this quarter's portfolio value
- Vanguard Morningstar Growth ETF9229087364.0%$50.0M
- Invesco QQQ Trust Series I46090E1033.6%$45.0M
- Vanguard Scottsdale FDS92206C4092.6%$32.6M
- Schwab Fundamental U.S. Large Company ETF8085247712.5%$30.5M
- Pacer US Cash Cows 100 ETF69374H8812.2%$27.9M
Biggest buys
New and added positions, by estimated amount bought
- Vanguard Scottsdale FDS92206C409+$24.0MAdded
- First Tr Exchange-Traded FD33739Q200+$10.6MAdded
- Schwab Fundamental U.S. Large Company ETF808524771+$3.03MAdded
- Fidelity Covington Trust316092782+$2.95MAdded
- J P Morgan Exchange Traded F46641Q159+$2.09MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Vanguard Scottsdale FDS92206C409+1.86 pp0.8% → 2.6%
- First Tr Exchange-Traded FD33739Q200+0.85 pp<0.1% → 0.9%
- Vanguard Morningstar Growth ETF922908736+0.27 pp3.8% → 4.0%
- Schwab Fundamental U.S. Large Company ETF808524771+0.25 pp2.2% → 2.5%
- iShares Tr46435G102+0.24 pp1.6% → 1.9%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- Fidelity Merrimack STR Tr316188309−$22.1MReduced
- SPDR Series Trust78464A383−$9.30MSold out
- SPDR Series Trust78464A672−$6.60MReduced
- Vanguard Intermediate-Term Bond ETF921937819−$5.75MReduced
- iShares U.S. Medical Devices ETF464288810−$4.41MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- Fidelity Merrimack STR Tr316188309−2.00 pp2.1% → 0.1%
- SPDR Series Trust78464A383−0.83 pp0.8% → 0.0%
- SPDR Series Trust78464A672−0.67 pp1.3% → 0.6%
- Vanguard Intermediate-Term Bond ETF921937819−0.67 pp1.9% → 1.2%
- iShares U.S. Medical Devices ETF464288810−0.46 pp0.6% → 0.2%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $1.24B
- +$125.1M (+11.2%) vs. prior quarter
- Positions
- 327
- +9 vs. prior quarter
- Top 10 concentration
- 24.7%
- Top 10 as share of value
- Turnover
- 6.6%
- Q2 2026, one quarter
- Average holding period
- 16.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.24B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 16, 2026 | 327 | $1.24B | Vanguard Morningstar Growth ETFInvesco QQQ Trust Series IVanguard Scottsdale FDS | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 17, 2026 | 318 | $1.12B | Vanguard Morningstar Growth ETFInvesco QQQ Trust Series IPacer US Cash Cows 100 ETF | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 12, 2026 | 317 | $1.10B | Vanguard Morningstar Growth ETFInvesco QQQ Trust Series IPacer US Cash Cows 100 ETF | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 13, 2025 | 315 | $1.05B | Vanguard Morningstar Growth ETFInvesco QQQ Trust Series IPacer US Cash Cows 100 ETF | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 303 | $962.1M | Vanguard Morningstar Growth ETFInvesco QQQ Trust Series IPacer US Cash Cows 100 ETF | vs. Q1 2025 | SEC |
| Q1 2025 | May 8, 2025 | 295 | $883.3M | Vanguard Morningstar Growth ETFPacer US Cash Cows 100 ETFInvesco QQQ Trust Series I | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 15, 2025 | 297 | $921.4M | Vanguard Morningstar Growth ETFPacer US Cash Cows 100 ETFInvesco QQQ Trust Series I | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 12, 2024 | 297 | $902.6M | Vanguard Morningstar Growth ETFPacer US Cash Cows 100 ETFInvesco QQQ Trust Series I | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 13, 2024 | 288 | $797.2M | Vanguard Morningstar Growth ETFPacer US Cash Cows 100 ETFInvesco QQQ Trust Series I | vs. Q1 2024 | SEC |
| Q1 2024 | May 10, 2024 | 266 | $716.8M | Vanguard Morningstar Growth ETFPacer US Cash Cows 100 ETFVanguard Morningstar Value ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 9, 2024 | 264 | $659.2M | Vanguard Morningstar Growth ETFVanguard Morningstar Value ETFPacer US Cash Cows 100 ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 284 | $543.8M | Vanguard Morningstar Growth ETFVanguard Morningstar Value ETFSchwab US Dividend Equity ETF | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 258 | $543.8M | Vanguard Morningstar Growth ETFVanguard Morningstar Value ETFiShares Tr | vs. Q1 2023 | SEC |
| Q1 2023 | May 17, 2023Amended | 274 | $562.6M | Vanguard Morningstar Growth ETFiShares TrVanguard Morningstar Value ETF | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 15, 2023 | 232 | $506.0M | iShares TrVanguard Morningstar Value ETFVanguard Morningstar Growth ETF | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 213 | $438.2M | iShares TrVanguard Morningstar Growth ETFVanguard Morningstar Value ETF | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 236 | $448.5M | iShares TrVanguard Morningstar Growth ETFVanguard Morningstar Value ETF | vs. Q1 2022 | SEC |
| Q1 2022 | May 13, 2022 | 249 | $470.6M | iShares TriShares Core S&P 500 ETFVanguard Morningstar Growth ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 218 | $453.4M | iShares TriShares Core S&P 500 ETFAAPL | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 246 | $411.6M | iShares TriShares Core S&P 500 ETFVanguard Morningstar Growth ETF | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 209 | $397.8M | iShares TriShares Core S&P 500 ETFVanguard Morningstar Growth ETF | vs. Q1 2021 | SEC |
| Q1 2021 | May 10, 2021 | 806 | $385.7M | iShares TriShares Core S&P 500 ETFVanguard Morningstar Growth ETF | – | SEC |